Li X, Chen S, Ding M, Ding H, Yang K
Discov Oncol. 2025; 16(1):302.
PMID: 40072722
PMC: 11903997.
DOI: 10.1007/s12672-025-01903-x.
Hadaya L, Vasa F, Dimitrakopoulou K, Saqi M, Shergill S, Edwards A
Brain Commun. 2025; 7(2):fcaf074.
PMID: 40066107
PMC: 11891483.
DOI: 10.1093/braincomms/fcaf074.
Li H, Qin Z, Huang X, Wei Z, Deng J
Heliyon. 2025; 11(4):e42720.
PMID: 40066042
PMC: 11891687.
DOI: 10.1016/j.heliyon.2025.e42720.
Zhang E, Ma Y, Liu Z, Zhang J, Liu W, Chen Y
J Transl Med. 2025; 23(1):301.
PMID: 40065365
PMC: 11892293.
DOI: 10.1186/s12967-025-06152-8.
Liu F, Gao S, Yin J, Song C, Mei Y, Wang Z
JOR Spine. 2025; 8(1):e70050.
PMID: 40061887
PMC: 11885168.
DOI: 10.1002/jsp2.70050.
Integrated Analysis to Reveal Heterogeneity of Tumor-Associated Neutrophils in Glioma.
Wang W, Li J, He Q, Liu C, Wang S, Zheng Z
Cancer Med. 2025; 14(5):e70745.
PMID: 40052358
PMC: 11886415.
DOI: 10.1002/cam4.70745.
Integration of multi-omics profiling reveals an epigenetic-based molecular classification of lung adenocarcinoma: implications for drug sensitivity and immunotherapy response prediction.
Wang N, Li Y, Wang Y, Wang W
Front Pharmacol. 2025; 16:1540477.
PMID: 40046740
PMC: 11879945.
DOI: 10.3389/fphar.2025.1540477.
Multi-omics insights into the molecular signature and prognosis of hypopharyngeal squamous cell carcinoma.
Ren Y, Xiong W, Feng C, Yu D, Wang X, Yang Q
Commun Biol. 2025; 8(1):370.
PMID: 40044946
PMC: 11882983.
DOI: 10.1038/s42003-025-07700-0.
A multidimensional approach reveals the function of lactylation related genes in osteoarthritis.
Luan S, Luan J
Sci Rep. 2025; 15(1):7743.
PMID: 40044764
PMC: 11882932.
DOI: 10.1038/s41598-025-89072-3.
The interplay between angiogenesis-associated genes and molecular, clinical, and immune features in bladder cancer.
Guo X, Yang J, Cao R, Hao G
Discov Oncol. 2025; 16(1):265.
PMID: 40042726
PMC: 11883062.
DOI: 10.1007/s12672-025-01966-w.
Molecular subtyping of stage I lung adenocarcinoma via molecular alterations in pre-invasive lesion progression.
Shang J, Jiang H, Zhao Y, Yang J, Lin Y, Zhang N
J Transl Med. 2025; 23(1):263.
PMID: 40038757
PMC: 11877874.
DOI: 10.1186/s12967-025-06316-6.
Determinants of response and molecular dynamics in HER2+ER+ breast cancers from the NA-PHER2 trial receiving HER2-targeted and endocrine therapies.
Callari M, Dugo M, Barreca M, Gyorffy B, Galbardi B, Vigano L
Nat Commun. 2025; 16(1):2195.
PMID: 40038334
PMC: 11880565.
DOI: 10.1038/s41467-025-57293-9.
Identification of intratumoral microbiome-driven immune modulation and therapeutic implications in diffuse large B-cell lymphoma.
Yijia Z, Li X, Ma L, Wang S, Du H, Wu Y
Cancer Immunol Immunother. 2025; 74(4):131.
PMID: 40029433
PMC: 11876501.
DOI: 10.1007/s00262-025-03972-x.
Cytotoxic KLRG1+ IL-7R- effector CD8+ T cells distinguish kidney transplant recipients controlling cytomegalovirus reactivation.
Sun Y, Sen S, Parmar R, Arakawa-Hoyt J, Cappelletti M, Rossetti M
Front Immunol. 2025; 16:1542531.
PMID: 40028342
PMC: 11868092.
DOI: 10.3389/fimmu.2025.1542531.
Ligand-receptor interactions combined with histopathology for improved prognostic modeling in HPV-negative head and neck squamous cell carcinoma.
Feng B, Zhao D, Zhang Z, Jia R, Schuler P, Hess J
NPJ Precis Oncol. 2025; 9(1):57.
PMID: 40021759
PMC: 11871237.
DOI: 10.1038/s41698-025-00844-6.
Integrative analysis of m7G methylation-associated genes prognostic signature with immunotherapy and identification of LARP1 as a key oncogene in head and neck squamous cell carcinoma.
Xu J, You Z, Zhu Z, Liu M, Zhang Z, Xu P
Front Immunol. 2025; 16:1520070.
PMID: 40018039
PMC: 11864954.
DOI: 10.3389/fimmu.2025.1520070.
Transcriptomic profile of RNA pseudouridine modification as a biomarker for cellular senescence associated with survival outcomes in colorectal cancer.
Gan Y, Yuan Z, Weng J, Huang M, Li T, Wu Y
BMC Biol. 2025; 23(1):61.
PMID: 40016751
PMC: 11866714.
DOI: 10.1186/s12915-025-02170-6.
Identification of E3 ubiquitin ligase-based molecular subtypes and prognostic signature regarding prognosis and immune landscape in bladder cancer.
Hu B, Zhao T, Li Y, Li K, Shen L, Zhu Q
Cancer Cell Int. 2025; 25(1):70.
PMID: 40016750
PMC: 11869681.
DOI: 10.1186/s12935-025-03703-3.
LOX iCAFs in HNSCC have the potential to predict prognosis and immunotherapy responses revealed by single cell RNA sequencing analysis.
Liu X, Li H, Wang Y, Zhang Q, Liu Y, Liu T
Sci Rep. 2025; 15(1):7028.
PMID: 40016474
PMC: 11868481.
DOI: 10.1038/s41598-025-91036-6.
An Immunogenic Cell Death-Related Gene Signature Predicts the Prognosis and Immune Infiltration of Cervical Cancer.
Sun F, Sun Y, Tian H
Cancer Inform. 2025; 24:11769351251323239.
PMID: 40008391
PMC: 11851768.
DOI: 10.1177/11769351251323239.